MedPath

SHR0532

Generic Name
SHR0532

Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension

Phase 1
Completed
Conditions
Hypertension
Interventions
First Posted Date
2019-06-03
Last Posted Date
2021-10-18
Lead Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Target Recruit Count
36
Registration Number
NCT03971929
Locations
🇨🇳

The second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Hangzhou, China

The PK/PD Study of SHR0532 Tablets in Healthy Subjects

Phase 1
Conditions
Hypertension
Interventions
Drug: Placebo
First Posted Date
2018-08-24
Last Posted Date
2018-08-24
Lead Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Target Recruit Count
50
Registration Number
NCT03645278
© Copyright 2025. All Rights Reserved by MedPath